These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 21449080)

  • 1. [Development of new nutrient medium for MDCK and Vero cells based on soy hydrolysate obtained using bromeline and assessment of growth characteristics of influenza virus vaccine strains cultivated on them].
    Mazurkova NA; Troshkova ; Shishkina LN; Stavskiĭ EA; Drozdov IG
    Zh Mikrobiol Epidemiol Immunobiol; 2011; (1):86-90. PubMed ID: 21449080
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Use of plant-origin components in roller cultivation of vaccine reassortant influenza virus strain H5N2].
    Mazurkova NA; Desheva IuA; Shishkina LN; Stavskiĭ EA; Rudenko LG
    Zh Mikrobiol Epidemiol Immunobiol; 2011; (2):88-92. PubMed ID: 21598624
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nutrient medium from rice flour hydrolysate for cell culturing and evaluation of the sensitivity to influenza viruses.
    Danlybaeva GA; Mazurkova NA; Matyushina RO; Troshkova GP; Podchernyaeva RY
    Bull Exp Biol Med; 2009 Apr; 147(4):547-50. PubMed ID: 19704969
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of egg and high yielding MDCK cell-derived live attenuated influenza virus for commercial production of trivalent influenza vaccine: in vitro cell susceptibility and influenza virus replication kinetics in permissive and semi-permissive cells.
    Hussain AI; Cordeiro M; Sevilla E; Liu J
    Vaccine; 2010 May; 28(22):3848-55. PubMed ID: 20307595
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MDCK and Vero cells for influenza virus vaccine production: a one-to-one comparison up to lab-scale bioreactor cultivation.
    Genzel Y; Dietzsch C; Rapp E; Schwarzer J; Reichl U
    Appl Microbiol Biotechnol; 2010 Sep; 88(2):461-75. PubMed ID: 20617311
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Production of cell culture (MDCK) derived live attenuated influenza vaccine (LAIV) in a fully disposable platform process.
    George M; Farooq M; Dang T; Cortes B; Liu J; Maranga L
    Biotechnol Bioeng; 2010 Aug; 106(6):906-17. PubMed ID: 20589670
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative analysis of reproduction of influenza virus strains in cell lines perspective for the creation of cultural vaccines grown on nutrient medium on the basis of rise flour protein hydrolysate.
    Mazurkova NA; Troshkova GP; Sumkina TP; Kolokol'tsova TD; Skarnovich MO; Kabanov AS; Shishkina LN; Sergeev AN
    Bull Exp Biol Med; 2008 Oct; 146(4):547-50. PubMed ID: 19489339
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Generation of a High-Growth Influenza Vaccine Strain in MDCK Cells for Vaccine Preparedness.
    Kim EH; Kwon HI; Park SJ; Kim YI; Si YJ; Lee IW; Kim SM; Kim SI; Ahn DH; Choi YK
    J Microbiol Biotechnol; 2018 Jun; 28(6):997-1006. PubMed ID: 29642288
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Immunogenicity of influenza virus H5N2 vaccine strain samples produced by roller cultivation in media with plant derived components].
    Mazurkova NA; Desheva IuA; Shishkina LN; Stavskiĭ EA; Rudenko LG
    Zh Mikrobiol Epidemiol Immunobiol; 2011; (3):48-52. PubMed ID: 21812141
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Construction high-yield candidate influenza vaccine viruses in Vero cells by reassortment.
    Yu W; Yang F; Yang J; Ma L; Cun Y; Song S; Liao G
    J Med Virol; 2016 Nov; 88(11):1914-21. PubMed ID: 27101353
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reassortment of high-yield influenza viruses in vero cells and safety assessment as candidate vaccine strains.
    Zhou J; Yang F; Yang J; Ma L; Cun Y; Song S; Liao G
    Hum Vaccin Immunother; 2017 Jan; 13(1):111-116. PubMed ID: 27648636
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison between MDCK and MDCK-SIAT1 cell lines as preferred host for cell culture-based influenza vaccine production.
    Abdoli A; Soleimanjahi H; Jamali A; Mehrbod P; Gholami S; Kianmehr Z; Feizi N; Saleh M; Bahrami F; Mokhtari-Azad T; Abdoli M; Kheiri MT
    Biotechnol Lett; 2016 Jun; 38(6):941-8. PubMed ID: 26945752
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum-free microcarrier based production of replication deficient influenza vaccine candidate virus lacking NS1 using Vero cells.
    Chen A; Poh SL; Dietzsch C; Roethl E; Yan ML; Ng SK
    BMC Biotechnol; 2011 Aug; 11():81. PubMed ID: 21835017
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Vero-cell-adapted vaccine donor strain of influenza A virus generated by serial passages.
    Hu W; Zhang H; Han Q; Li L; Chen Y; Xia N; Chen Z; Shu Y; Xu K; Sun B
    Vaccine; 2015 Jan; 33(2):374-81. PubMed ID: 25448099
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Infection dynamics and virus-induced apoptosis in cell culture-based influenza vaccine production-Flow cytometry and mathematical modeling.
    Schulze-Horsel J; Schulze M; Agalaridis G; Genzel Y; Reichl U
    Vaccine; 2009 May; 27(20):2712-22. PubMed ID: 19428884
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influenza viruses production: Evaluation of a novel avian cell line DuckCelt®-T17.
    Petiot E; Proust A; Traversier A; Durous L; Dappozze F; Gras M; Guillard C; Balloul JM; Rosa-Calatrava M
    Vaccine; 2018 May; 36(22):3101-3111. PubMed ID: 28571695
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of MDCK cells for production of live attenuated influenza vaccine.
    Liu J; Shi X; Schwartz R; Kemble G
    Vaccine; 2009 Oct; 27(46):6460-3. PubMed ID: 19559113
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Higher titers of some H5N1 and recent human H1N1 and H3N2 influenza viruses in Mv1 Lu vs. MDCK cells.
    Hamilton SB; Wyatt DE; Wahlgren BT; O'Dowd MK; Morrissey JM; Daniels DE; Lednicky JA
    Virol J; 2011 Feb; 8():66. PubMed ID: 21314955
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum-Free Suspension Culture of MDCK Cells for Production of Influenza H1N1 Vaccines.
    Huang D; Peng WJ; Ye Q; Liu XP; Zhao L; Fan L; Xia-Hou K; Jia HJ; Luo J; Zhou LT; Li BB; Wang SL; Xu WT; Chen Z; Tan WS
    PLoS One; 2015; 10(11):e0141686. PubMed ID: 26540170
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Y161F Hemagglutinin Substitution Increases Thermostability and Improves Yields of 2009 H1N1 Influenza A Virus in Cells.
    Wen F; Li L; Zhao N; Chiang MJ; Xie H; Cooley J; Webby R; Wang PG; Wan XF
    J Virol; 2018 Jan; 92(2):. PubMed ID: 29118117
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.